Role of Adiponectin in the Metabolic Syndrome: Current Perspectives on its Modulation as a Treatment Strategy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|32|5755-5763

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.32, 2013-10, pp. : 5755-5763

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Perspectives on the Drug Treatment of Neonatal Respiratory Distress Syndrome

By Sweet D.G.   Halliday H.L.  

Pediatric Drugs, Vol. 1, Iss. 1, 1999-01 ,pp. : 19-30

Adis International

Access to resources Recommend Favorite

Drug Treatment of Metabolic Syndrome

By  

Current Clinical Pharmacology, Vol. 8, Iss. 3, 2013-08 ,pp. : 224-231

Bentham Science Publishers

Access to resources Recommend Favorite

The role of zoledronic acid in the adjuvant treatment of breast cancer: current perspectives

By Tonyali Onder   Arslan Cagatay   Altundag Kadri  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 16, 2010-11 ,pp. : 2715-2725

Informa Healthcare

Access to resources Recommend Favorite

Adiponectin in health and diseases: from metabolic syndrome to tissue regeneration

By Chiarugi Paola   Fiaschi Tania  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 2, 2010-02 ,pp. : 193-206

Informa Healthcare

Access to resources Recommend Favorite

The Potential Role of Antioxidants in Metabolic Syndrome

By  

Current Pharmaceutical Design, Vol. 22, Iss. 7, 2016-02 ,pp. : 859-869

Bentham Science Publishers

Access to resources Recommend Favorite